Cue Health Debt to Equity Ratio 2020-2023 | HLTH
Current and historical debt to equity ratio values for Cue Health (HLTH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cue Health debt/equity for the three months ending December 31, 2023 was 0.00.
| Cue Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.09B | $0.25B | 0.36 |
| 2023-09-30 | $0.10B | $0.39B | 0.27 |
| 2023-06-30 | $0.10B | $0.42B | 0.24 |
| 2023-03-31 | $0.11B | $0.50B | 0.23 |
| 2022-12-31 | $0.12B | $0.58B | 0.21 |
| 2022-09-30 | $0.24B | $0.59B | 0.40 |
| 2022-06-30 | $0.27B | $0.64B | 0.43 |
| 2022-03-31 | $0.26B | $0.73B | 0.36 |
| 2021-12-31 | $0.23B | $0.71B | 0.33 |
| 2021-09-30 | $0.27B | $0.65B | 0.41 |
| 2021-06-30 | $0.00B | $0.00B | 0.00 |
| 2021-03-31 | $0.00B | $0.00B | 0.00 |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.022B | $0.071B |
| Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.473B | 21.40 |
| Inspire Medical Systems (INSP) | United States | $6.824B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.536B | 0.00 |
| Axonics (AXNX) | United States | $3.409B | 0.00 |
| 10x Genomics (TXG) | United States | $3.313B | 0.00 |
| Enovis (ENOV) | United States | $3.044B | 23.13 |
| Azenta (AZTA) | United States | $2.839B | 231.41 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.739B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.545B | 0.00 |
| Privia Health (PRVA) | United States | $2.142B | 95.00 |
| Schrodinger (SDGR) | United States | $1.771B | 0.00 |
| Omnicell (OMCL) | United States | $1.294B | 31.66 |
| Phreesia (PHR) | United States | $1.264B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.863B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.615B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.327B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.326B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.285B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.160B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.146B | 0.00 |
| Outset Medical (OM) | United States | $0.121B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.15 |
| 111 (YI) | China | $0.089B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |